Voya Investment Management LLC Gritstone Bio, Inc. Transaction History

Voya Investment Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Dec 06, 2024	BUY	$1.96 - $2.9 $55,079 - $81,495	28,102 New	28,102 $72,000
Q1 2024 May 15, 2024	SELL	$1.96 - $2.9 $14,700 - $21,750	-7,500 Reduced 21.07%	28,102 $72,000
Q2 2023 Aug 14, 2023	BUY	$1.66 - $3.03 $59,099 - $107,874	35,602 New	35,602 $69,000
Q2 2022 Aug 15, 2022	SELL	$1.77 - $4.34 $28,178 - $69,092	-15,920 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$8.76 - $13.71 $3,101 - $4,853	-354 Reduced 2.18%	15,920 $205,000
Q2 2021 Aug 16, 2021	BUY	$8.13 - $10.2 $18,690 - $23,449	2,299 Added 16.45%	16,274 $149,000
Q1 2021 May 17, 2021	SELL	$4.07 - $27.11 $6,157 - $41,017	-1,513 Reduced 9.77%	13,975 $132,000
Q4 2020 Feb 16, 2021	BUY	$2.57 - $4.22 $12,832 - $21,070	4,993 Added 47.58%	15,488 $61,000
Q2 2020 Aug 14, 2020	SELL	$5.69 - $8.17 $10,509 - $15,089	-1,847 Reduced 14.97%	10,495 $70,000
Q4 2019 Feb 14, 2020	BUY	$7.07 - $11.61 $87,257 - $143,290	12,342 New	12,342 $111,000

35.4M

395K

132K

Ticker GRTS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,006,896
Market Cap $2.19M
Description
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Voya Investment Management LLC with notifications on news.